These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22466291)

  • 1. False recognition in a mouse model of Alzheimer's disease: rescue with sensory restriction and memantine.
    Romberg C; McTighe SM; Heath CJ; Whitcomb DJ; Cho K; Bussey TJ; Saksida LM
    Brain; 2012 Jul; 135(Pt 7):2103-14. PubMed ID: 22466291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's-disease-model transgenic mice shown as by micromagnetic resonance imaging.
    Scholtzova H; Wadghiri YZ; Douadi M; Sigurdsson EM; Li YS; Quartermain D; Banerjee P; Wisniewski T
    J Neurosci Res; 2008 Sep; 86(12):2784-91. PubMed ID: 18615702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
    Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N
    Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
    Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
    J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early intervention with an estrogen receptor β-selective phytoestrogenic formulation prolongs survival, improves spatial recognition memory, and slows progression of amyloid pathology in a female mouse model of Alzheimer's disease.
    Zhao L; Mao Z; Chen S; Schneider LS; Brinton RD
    J Alzheimers Dis; 2013; 37(2):403-19. PubMed ID: 23948892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of eIF2α kinases alleviates Alzheimer's disease-related plasticity and memory deficits.
    Ma T; Trinh MA; Wexler AJ; Bourbon C; Gatti E; Pierre P; Cavener DR; Klann E
    Nat Neurosci; 2013 Sep; 16(9):1299-305. PubMed ID: 23933749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer's Disease.
    Ettcheto M; Sánchez-López E; Gómez-Mínguez Y; Cabrera H; Busquets O; Beas-Zarate C; García ML; Carro E; Casadesus G; Auladell C; Vázquez Carrera M; Folch J; Camins A
    Mol Neurobiol; 2018 Sep; 55(9):7327-7339. PubMed ID: 29404958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Memantine Treatment Ameliorates Behavioral Deficits, Neuron Loss, and Impaired Neurogenesis in a Model of Alzheimer's Disease.
    Stazi M; Wirths O
    Mol Neurobiol; 2021 Jan; 58(1):204-216. PubMed ID: 32914393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice.
    Sivilia S; Lorenzini L; Giuliani A; Gusciglio M; Fernandez M; Baldassarro VA; Mangano C; Ferraro L; Pietrini V; Baroc MF; Viscomi AR; Ottonello S; Villetti G; Imbimbo BP; Calzà L; Giardino L
    BMC Neurosci; 2013 Apr; 14():44. PubMed ID: 23560952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the drug combination memantine and melatonin on impaired memory and brain neuronal deficits in an amyloid-predominant mouse model of Alzheimer's disease.
    Jürgenson M; Zharkovskaja T; Noortoots A; Morozova M; Beniashvili A; Zapolski M; Zharkovsky A
    J Pharm Pharmacol; 2019 Nov; 71(11):1695-1705. PubMed ID: 31531878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memantine ameliorates cognitive deficit in AD mice via enhancement of entorhinal-CA1 projection.
    Li P; Xu J; Gu H; Peng H; Yin Y; Zhuang J
    BMC Neurosci; 2021 Jun; 22(1):41. PubMed ID: 34120588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced tissue levels of noradrenaline are associated with behavioral phenotypes of the TgCRND8 mouse model of Alzheimer's disease.
    Francis BM; Yang J; Hajderi E; Brown ME; Michalski B; McLaurin J; Fahnestock M; Mount HT
    Neuropsychopharmacology; 2012 Jul; 37(8):1934-44. PubMed ID: 22491352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Memantine Treatment and Combination with Vitamin D Supplementation on Body Composition in the APP/PS1 Mouse Model of Alzheimer's Disease Following Chronic Vitamin D Deficiency.
    Wong D; Broberg DN; Doad J; Umoh JU; Bellyou M; Norley CJD; Holdsworth DW; Montero-Odasso M; Beauchet O; Annweiler C; Bartha R
    J Alzheimers Dis; 2021; 81(1):375-388. PubMed ID: 33780366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer's disease mouse model.
    Faivre E; Hölscher C
    J Alzheimers Dis; 2013; 35(2):267-83. PubMed ID: 23568101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A TgCRND8 Mouse Model of Alzheimer's Disease Exhibits Sexual Dimorphisms in Behavioral Indices of Cognitive Reserve.
    Granger MW; Franko B; Taylor MW; Messier C; George-Hyslop PS; Bennett SA
    J Alzheimers Dis; 2016; 51(3):757-73. PubMed ID: 26890738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Time Course of Recognition Memory Impairment and Glial Pathology in the hAPP-J20 Mouse Model of Alzheimer's Disease.
    Ameen-Ali KE; Simpson JE; Wharton SB; Heath PR; Sharp PS; Brezzo G; Berwick J
    J Alzheimers Dis; 2019; 68(2):609-624. PubMed ID: 30814360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice.
    Martinez-Coria H; Green KN; Billings LM; Kitazawa M; Albrecht M; Rammes G; Parsons CG; Gupta S; Banerjee P; LaFerla FM
    Am J Pathol; 2010 Feb; 176(2):870-80. PubMed ID: 20042680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome.
    Lockrow J; Boger H; Bimonte-Nelson H; Granholm AC
    Behav Brain Res; 2011 Aug; 221(2):610-22. PubMed ID: 20363261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5XFAD transgenic model of Alzheimer's disease.
    Maya-Vetencourt JF; Carucci NM; Capsoni S; Cattaneo A
    J Alzheimers Dis; 2014; 42(1):103-7. PubMed ID: 24844685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of Radial Glial-Like Cells in the Hippocampus of APP/PS1 Mice: a Novel Mechanism of Memantine in the Treatment of Alzheimer's Disease.
    Sun D; Chen J; Bao X; Cai Y; Zhao J; Huang J; Huang W; Fan X; Xu H
    Mol Neurobiol; 2015 Aug; 52(1):464-77. PubMed ID: 25195698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.